Bayer upgrades temperature-controlled packaging and saves money while doing so
New design from Emball'Iso triples payload capacity
Medical marijuana looks for a place in conventional drug distribution
It's still early days in making medical marijuana--and cannabis-based pharmaceuticals--part of normal dispensing
Cloud-based services manage regulated content better
Unifying the management of clinical research documentation and marketing content saves time and accelerates speed-to-therapy
Advances in cold chain packaging
GDP standards drive higher performance standards for packaging
ACOs raise the stakes for evidence-based medicine
Manufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete
Pharmaceutical cold chain logistics is a $10-billion global industry
Pharmaceutical Commerce's annual Cold Chain Sourcebook projects 44% growth over the 2013-2019 span
FDA approves first biosimilar--but don't look for it on pharmacy shelves yet
'Filgrastim-sndz' is Sandoz' Zarxio, the biosimilar of Amgen's Neuprogen
TraceLink relocates to new offices as employment more than doubles
Success in managing DSCSA traceability requirements bring a $20-million equity investment
Next agg-spend reporting deadline looms with little buzz from industry
Reporting by pharma companies on spending on physicians is becoming a non-event
Healthcare providers continue to criticize Genentech's limited-distribution action
Last year's decision will cost US hospitals $300 million, says Novation-led group
Cardinal Health will acquire J&J's Cordis for $1.94 billion
Emphasis of 'physician preference items' in healthcare distribution
The biosimilars payoff in the US might be small and fleeting
Analysis from Prime Therapeutics points to severe cost hurdles for biosimilars developed and marketed in the US
US health exchanges' formulary policies begin to shape up
However, most payers will continue to adjust their drug coverage
PDA releases technical report on drug shortages as a free download
Step-by-step process for addressing potential shortages is outlined
Exostar grows its network of collaborative tools in life sciences
Identity Hub expedites access to regulated content in clinical research; now, prescribing and other commercial applications are being adopted
Symphony Health Solutions builds a 5-million-patient, longitudinal cardiovascular registry
Collaboration with American College of Cardiology could result in new health-outcomes results
IAG Cargo touts its global network of certified cargo centers for pharmaceutical shipments
Nearly 100 cargo stations have been enhanced for pharma cold-chain distribution
AmerisourceBergen World Courier opens new distribution center in Australia
First of what are expected to be many global 3PL sites, especially for specialty pharmaceuticals
Rite Aid to buy EnvisionRx, continuing a reshaping of US drug distribution
$2-billion acquisition brings a $5-billion/yr PBM to Rite Aid's 4,600 retail stores
UPS Healthcare Logistics adds prequalified packages to its cold chain services
Service eases the management of domestic US shipments to trading partners and patients
Relief supplies continue to flow to West Africa as response 'pivots toward recovery'
Vaccine trials will continue without a clear path forward
Cold Chain Technologies pairs with NanoCool for 'push button' refrigeration
KoolTemp GTS Instant avoids use--and cost--of refrigerants
Whole and fractionated blood product markets are shifting, says Kalorama Information
Whole blood use is declining while plasma-derived product consumption rises
Independent physicians and their clinics remain a dominant channel for specialty distribution, says HDMA
Annual specialty-distribution study focuses trend in oncology, chronic diseases
Campbell Alliance updates, expands its commercial-launch consulting services
More executional capabilities derive from affiliation with parent, inVentiv Health
HealthPrize touts its success with 'gamification' in adherence programs
Company uses online media to promote fill rates by over 50%
Valeant's bid for Dendreon assets could put it in the oncology business
$296-million bid makes it the 'stalking horse' buyer in Dendreon auction
FDA records a banner year in new-drug approvals, with 41
Roughly 40% are for rare diseases; PD-1 oncolytics capture industry attention
With acquisition of OptumHealth assets, Mapi Group bids to capture health economics consulting work globally
Mapi Group casts itself as a leading 'health research and commercialization' player
Doximity crosses 50% line of engagement with physician population
'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney
